Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Article

Title: Banking on Human Embryonic Stem Cells

Author: Staff Article Type: Product Analysis
Source: Genetic Engineering News, v27 n8 p16(1) Publication Date: Apr 15, 2007
  Illustrations: Output Samples, Charts
URL of Publication: http://www.genengnews.com

Advanced Cell Technology, a California company active in the hESC (human embryonic stem cell) field since the first hESC line isolation in 1998, is highlighted in a discussion of the company's efforts to convert basic research into regenerative medicine. California voters approved Prop 71, a $3 billion California Stem Cell Research and Cures Initiative in late 2004. The California Institute for Regenerative Medicine (DIRM) awarded $45 million in 72 grants during 2007 to researchers at 20 universities and non-profit research laboratories throughout California. The first Scientific Excellence Through Exploration and Development (SEED) grants went to investigators looking at hESC research. Advanced Cell Technology is well positioned to transform basic research into tangible, practical techniques in regenerative medicine, said chairman and CEO William M. Caldwell, IV. There are stringent restrictions on hESC experimentation that have been imposed by the federal government. New York, New Jersey, and Massachusetts CIRM programs and others will be inefficiently implemented because there will be duplication of the infrastructure of neighboring states in the areas of bureaucracy. Therefore, says Mr. Caldwell, the correct funding source for hESC should be centralized, and he prefers centralization at National Institutes of Health (NIH).

Special Features: Output Samples, Charts

Companies:
Advanced Cell Technology Inc

Products:
Government Funding
Human Embryonic Stem Cells Regenerative Medicine
Stem Cell Research

TecTerms:


[Get Copyright Permissions] Click here for copyright permissions!
Copyright 2004-2008 Information Sources Inc.
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.